Life Sciences 1995-01-01

7-Nitro indazole derivatives are potent inhibitors of brain, endothelium and inducible isoforms of nitric oxide synthase.

P A Bland-Ward, P K Moore

Index: Life Sci. 57 , PL131-PL135, (1995)

Full Text: HTML

Abstract

The effect of 7-nitro indazole (7-NI) and a range of substituted indazole derivatives on nitric oxide synthase (NOS) enzyme activity in homogenates of rat cerebellum, bovine endothelial cells and lung from endotoxin-pretreated rats was investigated. 3-bromo 7-nitro indazole was either equipotent (IC50, 0.86 +/- 0.05 microM c.f. 0.78 +/- 0.2 microM, n = 6, P > 0.05) or approximately 4x (IC50, 0.17 +/- 0.01 microM c.f. 0.71 +/- 0.01 microM, n = 6, P < 0.05) or 20x (IC50, 0.29 +/- 0.01 microM c.f. 5.8 +/- 0.4 microM, n = 6, P < 0.05) more potent than 7-NI as an inhibitor of bovine endothelial, rat cerebellar and rat lung NOS enzyme activity respectively. 2,7-dinitro indazole also inhibited NOS in all three tissue sources with a potency similar to that of 7-NI. These results suggest that 3-bromo 7-NI and 2,7-dinitro indazole may prove to be useful additional tools with which to examine the biological properties of nitric oxide (NO).


Related Compounds

Related Articles:

Metaplastic effects of subanesthetic ketamine on CA1 hippocampal function.

2014-11-01

[Neuropharmacology 86 , 273-81, (2014)]

Role of nitric oxide in traumatic brain injury in the rat.

1998-11-01

[J. Neurosurg. 89 , 807-818, (1998)]

The role of nitric oxide in the pathophysiology of thromboembolic stroke in the rat.

1997-06-06

[Brain Res. 759 , 32-40, (1997)]

Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia.

1997-06-20

[Brain Res. 760 , 170-178, (1997)]

S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson's disease.

2013-01-01

[Molecular Neurodegeneration 8 , 29, (2013)]

More Articles...